Effect of Glycemic Control on Adipokines in Diabetic Patients with Pulmonary Hypertension

NADER KANDIL, M.D., MANAR M. EL-ZAKI, M.D.;; MAI M. HASAN, M.D., SAMIA HUSSEIN, M.D.;; SAEED, M.D., ABEER A.

doi:10.21608/mjcu.2019.52636

Effect of Glycemic Control on Adipokines in Diabetic Patients with Pulmonary Hypertension

Document Type : Original Article

Authors

The Departments of Cardiology*, Medical Biochemistry & Molecular Biology** and Medical Physiology***, Faculty of Medicine, Zagazig University, Egypt

10.21608/mjcu.2019.52636

Abstract

Abstract
Background: Recent studies suggested a role of diabetes in regulating the outcome of pulmonary hypertension. Several cytokines are dysregulated in pulmonary hypertension, and were considered accurate predictors of the prognosis.
Aim of Study: To evaluate the effects of glycemic control on hemodynamics, metabolic and adipokines (leptin, apelin and adiponectin) levels in patients with pulmonary hyperten-sion and diabetes.
Subjects and Methods: Thirty-five pulmonary hypertension patients with diabetes assigned into two groups according to glycosylated hemoglobin (HbA1c) level; tightly controlled group (Group I) (n=20) and conventionally controlled group (Group II) (n=15). Demographic characteristics, hemodynamic assessment, metabolic and serum adipokines levels were assesed.
Results: Both groups showed insignificant difference in age, BMI and left ventricular ejection fraction; while mean pulmonary arterial pressure, HbA1c, fasting blood glucose, insulin, HOMA-IR, Cholesterol, triglycerides, Interleukin-6, leptin and apelin were significantly decreased in group I. IL-6, leptin and apelin have significant positive correlation with glucose, insulin, HOMA-IR, Cholesterol, TG and MPAP in both groups.
Conclusion: Good glycemic control has an impact on hemodynamics, metabolic, inflammatory and adipokine pattern in diabetic patients with pulmonary hypertension, which may affect the progression of the disease.

Keywords